Content about Valeant Pharmaceuticals

February 13, 2012
Valeant to acquire Eyetech

Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.

February 6, 2012
Mylan acquires rights to two Valeant drugs

Mylan has completed its acquisition of two skin drugs from Valeant Pharmaceuticals, the generic drug maker said Monday.

January 30, 2012
Valeant withdraws acquisition offer for Ista

Valeant Pharmaceuticals said it would not move forward in its pursuit of Ista Pharmaceuticals due to lack of progress.

December 22, 2011
Valeant completes iNova acquisition

Canadian drug maker Valeant Pharmaceuticals officially owns an Australian drug maker.

December 19, 2011
Valeant launches hostile takeover bid for ISTA

Drug maker Valeant Pharmaceuticals has launched a hostile takeover bid for ISTA Pharmaceuticals, the company said.

November 11, 2011
Valeant names CFO

A former Goldman Sachs executive will join Valeant Pharmaceuticals as EVP and CFO.

August 18, 2011
Board member at Valeant steps down

Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.

July 15, 2011
Valeant Pharmaceuticals purchases Johnson & Johnson dermatology subsidiary

Valeant Pharmaceuticals has purchased a dermatology subsidiary from Johnson & Johnson, the Canadian drug maker said Friday.

May 18, 2011
Valeant's Kinerase brand to make charitable donations as part of campaign

Valeant Pharmaceuticals has announced the launch of the "Change Your Skin, Change Your Life" campaign, in which its Kinerase brand will make three charitable donations in 2011.

March 30, 2011
Valeant seeks to buy Cephalon

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 22, 2011
Valeant CEO named chairman of the board

J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.

February 8, 2011
Biovail Labs to distribute Aczone in Canada

Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

December 20, 2010
Valeant names interim CFO

Valeant Pharmaceuticals' former SVP and corporate controller has been appointed to the role of interim CFO.

September 1, 2010
Teva markets AcuDial generic

Teva Pharmaceuticals has launched a generic treatment for epileptic seizures....

August 30, 2010
FDA pushes back GSK-Valeant drug review

The Food and Drug Administration has pushed back its review date for a drug made...

June 22, 2010
Valeant announces market availability of Oxsoralen-Ultra

Valeant Pharmaceuticals has made a treatment for psoriasis available again, following a shortage, the drug...

© 2012 Drug Store News. All Rights Reserved.